Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Abiomed Inc (ABMD)

Abiomed Inc (ABMD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 16,109,900
  • Shares Outstanding, K 45,380
  • Annual Sales, $ 847,520 K
  • Annual Income, $ 225,530 K
  • 60-Month Beta 1.31
  • Price/Sales 19.16
  • Price/Cash Flow 67.53
  • Price/Book 12.94
Trade ABMD with:

Options Overview

Details
  • Implied Volatility 38.13%
  • Historical Volatility 19.26%
  • IV Percentile 30%
  • IV Rank 29.51%
  • IV High 60.48% on 10/28/20
  • IV Low 28.78% on 08/06/21
  • Put/Call Vol Ratio 1.34
  • Today's Volume 491
  • Volume Avg (30-Day) 268
  • Put/Call OI Ratio 4.63
  • Today's Open Interest 940
  • Open Int (30-Day) 1,354

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate 0.98
  • Number of Estimates 7
  • High Estimate 1.22
  • Low Estimate 0.78
  • Prior Year 1.01
  • Growth Rate Est. (year over year) -2.97%

Price Performance

See More
Period Period Low Period High Performance
1-Month
347.24 +0.24%
on 09/20/21
376.99 -7.67%
on 09/07/21
-0.02 (-0.01%)
since 08/20/21
3-Month
305.76 +13.84%
on 07/15/21
376.99 -7.67%
on 09/07/21
+29.51 (+9.26%)
since 06/18/21
52-Week
242.73 +43.40%
on 10/30/20
387.40 -10.15%
on 01/28/21
+83.01 (+31.32%)
since 09/18/20

Most Recent Stories

More News
Here's Why You Should Retain Abiomed (ABMD) Stock For Now

Investors continue to be optimistic about Abiomed (ABMD) owing to its strength in the Impella product line.

ISRG : 1,004.36 (-3.17%)
HSIC : 75.27 (-2.84%)
ABMD : 346.43 (-2.41%)
IDXX : 653.69 (-1.21%)
Abiomed's (ABMD) Impella ECP Gets FDA's Breakthrough Device Tag

Abiomed's (ABMD) Impella ECP is likely to offer critical hemodynamic support to a wider pool of coronary artery disease patients.

ISRG : 1,004.36 (-3.17%)
HSIC : 75.27 (-2.84%)
ABMD : 346.43 (-2.41%)
IDXX : 653.69 (-1.21%)
FDA Grants Breakthrough Device Designation to Impella ECP, the World's Smallest Heart Pump

The United States Food and Drug Administration (FDA) has granted breakthrough device designation to Abiomed's (NASDAQ: ABMD) Impella ECP expandable percutaneous heart pump. The designation means the FDA...

ABMD : 346.43 (-2.41%)
Here's Why You Should Retain Abiomed (ABMD) Stock for Now

Investors continue to be optimistic about Abiomed (ABMD) owing to its strength in the Impella product line.

HSIC : 75.27 (-2.84%)
ABMD : 346.43 (-2.41%)
MMSI : 70.86 (-1.10%)
COO : 427.57 (-2.07%)
Abiomed's (ABMD) Q1 Earnings and Revenues Beat, Margins Up

Abiomed's (ABMD) strength in Impella product revenues drives its Q1 top line.

ABMD : 346.43 (-2.41%)
WST : 442.32 (-1.40%)
HRC : 150.09 (-0.27%)
EHC : 73.94 (-2.61%)
Abiomed (ABMD) Beats Q1 Earnings and Revenue Estimates

Abiomed (ABMD) delivered earnings and revenue surprises of 3.77% and 3.60%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

ABMD : 346.43 (-2.41%)
Abiomed: Fiscal Q1 Earnings Snapshot

DANVERS, Mass. (AP) _ Abiomed Inc. (ABMD) on Wednesday reported a fiscal first-quarter loss of $26.5 million, after reporting a profit in the same period a year earlier.

ABMD : 346.43 (-2.41%)
Abiomed Announces Record Revenue of $253 Million, Up 53% Year Over Year

Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, today announced financial results for the quarter ended June 30, 2021.

ABMD : 346.43 (-2.41%)
Medical Products' Aug 5 Earnings Roster: BDX, RMD & More

Let's see how Medical Product companies' stocks like BDX, RMD, CAH, ABMD and XRAY are poised ahead of their earnings releases.

ABT : 124.25 (-2.00%)
BDX : 258.63 (-1.27%)
CAH : 51.24 (-2.53%)
XRAY : 59.03 (-3.59%)
RMD : 281.62 (-1.51%)
ABMD : 346.43 (-2.41%)
Abiomed (ABMD) Reports Next Week: Wall Street Expects Earnings Growth

Abiomed (ABMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ABMD : 346.43 (-2.41%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Abiomed, Inc. is a provider of mechanical circulatory support devices and offers a continuum of care to heart failure patients. The Company develops, manufactures and markets proprietary products that are designed to enable the heart to rest, heal and recover by improving blood flow and/or performing...

See More

Key Turning Points

3rd Resistance Point 364.54
2nd Resistance Point 360.80
1st Resistance Point 357.90
Last Price 346.43
1st Support Level 351.26
2nd Support Level 347.52
3rd Support Level 344.62

See More

52-Week High 387.40
Last Price 346.43
Fibonacci 61.8% 332.14
Fibonacci 50% 315.07
Fibonacci 38.2% 297.99
52-Week Low 242.73

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar